UnitedHealth Group (NYSE: UNH ) reported earnings on July 19. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), UnitedHealth Group met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share improved.
Gross margins expanded, operating margins dropped, net margins dropped.
UnitedHealth Group recorded revenue of $27.27 billion. The 17 analysts polled by S&P Capital IQ expected net sales of $27.33 billion on the same basis. GAAP reported sales were 8.0% higher than the prior-year quarter's $25.23 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.27. The 22 earnings estimates compiled by S&P Capital IQ anticipated $1.19 per share. GAAP EPS of $1.27 for Q2 were 9.5% higher than the prior-year quarter's $1.16 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 26.6%, 20 basis points better than the prior-year quarter. Operating margin was 8.2%, 10 basis points worse than the prior-year quarter. Net margin was 4.9%, 10 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $27.49 billion. On the bottom line, the average EPS estimate is $1.27.
Next year's average estimate for revenue is $109.95 billion. The average EPS estimate is $5.01.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 3,295 members out of 3,447 rating the stock outperform, and 153 members rating it underperform. Among 975 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 956 give Unitedhealth Group a green thumbs-up, and 19 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on UnitedHealth Group is outperform, with an average price target of $68.38.
More Expert Advice from The Motley Fool
When President Obama was reelected, shares of UnitedHealth and other health insurers fell immediately. Is Obamacare a death knell for health insurers, or is the market missing out on some of the opportunities the law presents? In this brand new premium report on UnitedHealth, we take the long term view, honing in on prospects for UnitedHealth in a post-Obamacare world
. The report also comes with a full year of analyst updates to keep you covered as key news develops, so don't miss out - simply click here now
to claim your copy today.